Genetic changes could indicate whether a woman's breast cancer will come back, researchers have found. Around 55,000 women are diagnosed with breast cancer each year in the UK, and if it returns as secondary breast cancer it cannot be cured. But scientists now believe they can test the DNA of women taking hormonal therapy to work out whether they're at a high risk of the deadly secondary cancer. This'promising' discovery could help at-risk women get early treatment or prevention, they said. Researchers at the University of Edinburgh studied tumours from 62 women who took breast cancer drugs called aromatase inhibitors.
The'cell of origin' thought to trigger all types of cancer and allow the disease to spread has been found, scientists claim. Laboratory tests showed the cell to blame cheats death and breaks out of a zombie-like state to run amok and create a tumour. Salford University researchers have described their discovery as being like managing to find the proverbial'needle in a haystack'. But the findings, hoped to rewrite medical textbooks on the growth of cancer, could be a blow to existing treatments, such as chemotherapy. Professor Michael Lisanti, study author, said: 'We may have to press the reset button on how we treat cancer with drugs.'
Facebook and Google are not the only ones who are taking serious measures against the proliferation of "fake news". SEE ALSO: Experts don't know if the fake news problem will get more or less awful The UK's leading cancer charity, Macmillan, has appointed a digital nurse who will answer questions from patients on social media and help dispel myths around cancer, it said in a press release. The charity said there's a growing percentage of patients who Google their diagnosis without adequate support and could end up "needlessly frightened" and at risk of "bogus cures". Research conducted by YouGov found out that 42% of people with cancer looked up information about their diagnosis online, and of those 1 in 8 said they didn't fully understand their diagnosis. Ellen McPake, the nurse appointed for the digital role, will flank the charity's social media team and online community to work as one team.
There could be more than 3,500 avoidable cancer deaths in England in the next five years as a result of the coronavirus pandemic, researchers say. The virus had disrupted services and some people had avoided healthcare, they told The Lancet Oncology journal. The team looked at the likely impact on four major types of cancer - breast, colorectal, oesophageal and lung. Early diagnosis and treatment can save lives and anyone who suspects they may have cancer should seek help. During lockdown, some cancer services were scaled back or delayed, although people were still encouraged to have any essential or urgent care.
A blood test that can detect 10 types of cancer potentially years before someone becomes ill has been described as the'holy grail' of cancer research. Scientists in the US have found a simple test can pick up early signs of cancers including breast, ovarian, bowel and lung cancer. It works by picking up fragments of DNA released into the blood by fast-growing cancer cells. In a study of more than 1,400 people, the triple test achieved up to 90 per cent accuracy. Among four cancer-free people who tested positive, the US authors say two women were diagnosed with ovarian and endometrial cancer just months later.